文献速递主动脉疾病

肾下型EVAR及CTA随访所致额外癌症风险的估算

Estimation of the Added Cancer Risk Derived From EVAR and CTA Follow-Up.
PubMed 文献 · J Endovasc Ther · 2023-12-22

本研究基于95例和45例男性患者的辐射暴露数据,估算CTA与EVAR术的器官特异性吸收剂量,计算14个器官的终生归因风险(LAR)。结果显示总超额癌症风险为0.0046(1/220),其中手术和术前CTA贡献38%,其余来自随访;若完全取消CTA随访,仍残留0.0018(1/560)的超额风险。

要点

  • 肾下型EVAR及术前、术后每年CTA随访的总超额癌症风险为0.0046,即1/220患者将发生肿瘤。
  • 手术和术前CTA贡献总超额风险的38%,其余来自随访CTA。
  • 若完全取消CTA随访,仍残留超额风险0.0018(1/560)。

核心结论

  • 接受肾下型腹主动脉瘤EVAR的患者中,1/219因手术及术前和随访CTA相关辐射暴露而有终生发生癌症的风险,该风险主要来自每年术后CTA,提示减少或替代其使用有潜在获益。
  • 作者认为应努力减少术中辐射和随访中CTA的数量。

研究设计与样本

  • 基于模拟的估算研究,从95例和45例男性患者的辐射暴露分别估算CTA和EVAR术的器官特异性吸收辐射剂量。
  • 对14个不同器官计算终生归因风险(LAR)癌症预测,预期寿命取自既往肾下型EVAR患者队列。

主要发现

  • 计算的总超额癌症风险为0.0046,即1/220患者在接受术前CTA、EVAR术及15年每年CTA检查的电离辐射后将发生肿瘤。
  • 手术和术前CTA贡献总超额风险的38%,其余来自随访。
  • 若完全取消基于CTA的随访,仍残留超额风险0.0018(1/560)。
  • 接受肾下型腹主动脉瘤EVAR的患者中,1/219有因手术及术前和随访CTA相关辐射暴露而发生癌症的终生风险。

关键数值与推荐

  • 总超额癌症风险0.0046(1/220)。
  • 手术和术前CTA贡献总超额风险的38%。
  • 完全取消CTA随访后残留超额风险0.0018(1/560)。
  • 接受肾下型腹主动脉瘤EVAR的患者终生癌症风险为1/219。

临床怎么用

  • 作者认为该风险主要来自每年术后CTA,提示减少或替代其使用有潜在获益。
  • 作者认为应努力减少术中辐射和随访中CTA的数量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to assess the risk of radiation-induced cancer development in patients that have undergone an infrarenal EVAR, stratifying the relative contributions of the procedure and the preoperative and postoperative CTAs. METHODS AND MATERIALS: The organ-specific absorbed radiation doses from CTA and the EVAR procedure were estimated from the radiation exposures of 95 and 45 male patients, respectively. Lifetime attributable risk (LAR) cancer predictions were calculated for 14 different organs. Life expectancy was assumed from a previous cohort of patients undergoing infra-renal EVAR. RESULTS: The calculated total excess cancer risk was 0.0046, ie, 1 out of 220 patients will develop a neoplasm after being exposed to the ionizing radiation from the preoperative CTA, the EVAR and annual CTA examinations for 15 years. The procedure and the preoperative CTA contributed with 38% of the total excess risk, while the rest was derived from the follow-up. If the entire CTA based follow-up would have been eliminated, an excess risk of 0.0018 (1/560) would remain. CONCLUSIONS: 1 out of 219 patients who have undergone EVAR of an infra-renal AAA have a lifetime risk of developing cancer secondary to the radiation exposures related to the procedure and the CTAs used preoperatively and during follow-up. This risk derives mostly from the yearly postoperative CTAs, underlining the potential benefits of reducing or replacing their use.Clinical ImpactA simulation-based estimation reinforced the potential deleterious effects of the radiation exposure for patients undergoing Endovascular Aneurysm Repair (EVAR) of Abdominal Aortic Aneurysms (AAA) and subsequently followed by yearly Computer Tomography Angiographies (CTAs). The risk could be as high as 1 out 219 patients developing a neoplasm after 15 years. The largest exposure derives from the follow-up CTAs and efforts to minimize their use as well as the intraoperative radiation are greatly needed. The simulation-based estimations done in this study reinforce potential deleterious effects of the radiation exposure for patients undergoing EVAR of AAA. Efforts should be done to minimize the intraoperative radiation and the number of CTAs used during follow-up.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Singh B, Andersson M, Edsfeldt A, et al. Estimation of the Added Cancer Risk Derived From EVAR and CTA Follow-Up. J Endovasc Ther. 2023. PMID: 38140719. doi:10.1177/15266028231219435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。